Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days

New upgrade: Journal your trades with more detail

Onconetix, Inc.

Contributing Author

Recent Articles by Onconetix, Inc.

Aug-06	Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series ONCO -10.08% GlobeNewswire
Aug-05	Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG ONCO +20.42% GlobeNewswire
Jul-07	Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation ONCO GlobeNewswire
Jun-24	Onconetix Highlights Realbotix's Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District ONCO -6.54% GlobeNewswire
May-19	Onconetix, Inc. Announces 1-for-10 Reverse Stock Split ONCO -61.56% GlobeNewswire
May-13	Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study ONCO -5.10% GlobeNewswire
Apr-09	Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson ONCO +7.96% GlobeNewswire
Apr-02	Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update ONCO -18.94% GlobeNewswire
Mar-31	Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors ONCO -5.10% GlobeNewswire
Mar-25	Onconetix Highlights Realbotix's Role in Ericsson's World-First 6G Trial Demonstration ONCO +5.67% ONCO +6.27% GlobeNewswire
Mar-23	Onconetix, Inc. Announces 1-for-5 Reverse Stock Split ONCO GlobeNewswire
Feb-12	Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company ONCO -42.70% GlobeNewswire
Sep-26	Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc. ONCO +6.27% GlobeNewswire
Sep-26	Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement ONCO +6.27% GlobeNewswire
Sep-22	Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM ONCO GlobeNewswire
Jul-16	Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement ONCO -22.52% GlobeNewswire
Jun-16	Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel ONCO -9.94% GlobeNewswire
Jun-11	Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders ONCO -15.89% GlobeNewswire
May-22	Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq ONCO ONCO -14.00% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)